🇺🇸 Quadrivalent Influenza Vaccine in United States

Quadrivalent Influenza Vaccine (Quadrivalent Influenza Vaccine) regulatory status in United States.

Marketing authorisation

FDA

Status: approved

Pricing & reimbursement

annual_list: USD 13980.00 per year

Quadrivalent Influenza Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

🇪🇺 European Union

Other Immunology approved in United States

Frequently asked questions

Is Quadrivalent Influenza Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Quadrivalent Influenza Vaccine in United States?

International Centre for Diarrhoeal Disease Research, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Quadrivalent Influenza Vaccine cost in United States?

annual_list: USD 13980.00 per year. Final patient cost depends on reimbursement and any patient access scheme.